Back

The non-Lp(a) ApoB-to-Lp(a) ratio as an integrative biomarker of coronary plaque burden and vulnerability: insights from PROSPECT II

29 August 2026 (13:35 - 13:45)
Organised by: Logo
Congress Presentation Part of: Decoding plaque vulnerability: inflammation, lipoproteins, and intracoronary imaging insights Vulnerable Plaque ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Sotirios Tsimikas

University of California San Diego, La Jolla (United States of America)

5 More presentations in this session

Presentation thumbnail
Activation of ASIC3 attenuates thrombogenesis: a self-protective mechanism of the body
Doctor P. Zhang (Shanghai, CN)
Abstract Slides
Presentation thumbnail
Macrophage FOXK2 promotes cardiac repair in myocardial infarction with stress hyperglycemia
Doctor J. Jin (Beijing, CN)
Abstract Slides
Presentation thumbnail
Comparative impact of local and systemic inflammation on vessel-oriented outcomes following PCI in coronary artery disease
Mr Z. Ye (Beijing, CN)
Abstract Slides
Presentation thumbnail
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study
Doctor P. C Revaiah (New York, US)
Abstract Slides
Presentation thumbnail
Does lipoprotein(a) associate with coronary high-risk plaque in patients without hypercholesterolemia? Insights from optical coherence tomography imaging
Doctor C. Fang (Harbin, CN)
Abstract Slides

Access the full session

Session thumbnail
Decoding plaque vulnerability: inflammation, lipoproteins, and intracoronary imaging insights
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 13:35 CET
You may be interested in
thumbnail
Congress Presentation
Sex-specific influence of lipoprotein(a) levels on coronary plaque characteristics: the COPRODUCTION-registry
1 September 2025
thumbnail
Congress Presentation
Apolipoprotein B/apolipoprotein A-I ratio is comparable with C-reactive protein in predicting cancer mortality: results from two multi-ethnic US populations.
1 September 2019
thumbnail
Congress Presentation
Discordance between LDL cholesterol and apolypoprotein B. Which to prefer to guide treatment?
13 April 2023
thumbnail
Congress Presentation
Influence of the non-lipoprotein(a) apolipoprotein B/lipoprotein(a) ratio and other risk factors on coronary arterial aterosclerotic burden in acute coronary syndrome.
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources